FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Transbound Emerg Dis / Re-parameterization of a mathematical model of African horse...
Transboundary and emerging diseases2022; 69(4); e671-e681; doi: 10.1111/tbed.14420

Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search.

Abstract: African horse sickness (AHS) is a vector-borne disease transmitted by Culicoides spp., endemic to sub-Saharan Africa. There have been many examples of historic and recent outbreaks in the Middle East, Asia and Europe. However, not much is known about infection dynamics and outbreak potential in these naive populations. In order to better inform a previously published ordinary differential equation model, we performed a systematic literature search to identify studies documenting experimental infection of naive (control) equids in vaccination trials. Data on the time until the onset of viraemia, clinical signs and death after experimental infection of a naive equid and duration of viraemia were extracted. The time to viraemia was 4.6 days and the time to clinical signs was 4.9 days, longer than the previously estimated latent period of 3.7 days. The infectious periods of animals that died/were euthanized or survived were found to be 3.9 and 8.7 days, whereas previous estimations were 4.4 and 6 days, respectively. The case fatality was also found to be higher than previous estimations. The updated parameter values (along with other more recently published estimates from literature) resulted in an increase in the number of host deaths, decrease in the duration of the outbreak and greater prevalence in vectors.
© 2021 The Authors. Transboundary and Emerging Diseases published by Wiley-VCH GmbH.
Get Full Text
Publication Date: 2022-01-12 PubMed ID: 34921513PubMed Central: PMC9543668DOI: 10.1111/tbed.14420Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Systematic Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers in this study sought to better understand African horse sickness and its transmission dynamics by adjusting parameters in a previously developed mathematical model based on newer, more precise data gathered from a systematic literature review.

Context and Purpose

  • African horse sickness (AHS) is a disease primarily affecting horses and is transmitted by Culicoides species. This disease is mostly found in sub-Saharan Africa, but sporadic outbreaks have been recorded in Asia, Europe, and the Middle East.
  • Despite the widespread impact of AHS, very little is known about how the disease spreads or how outbreaks occur in previously unaffected populations.
  • The purpose of this study was to refine an existing mathematical model of AHS transmission. This was done by using updated data collected from a systematic review of literature on the experimental infection of unvaccinated, or ‘naive’, horses.

Methodology

  • Researchers carried out a systematic literature review to find studies that documented experimental infection trials in naive equines, or horses that had not been previously vaccinated against AHS.
  • From these studies, they obtained data on the interval between infection and the appearance of viremia (the presence of viruses in the blood), the occurrence of clinical symptoms, and death. They also collected data on the duration of viremia.

Findings

  • The researchers found that the time from infection to the onset of viremia was approximately 4.6 days, and the time from infection to the appearance of clinical symptoms was about 4.9 days. These times are longer than the earlier estimated latent period of 3.7 days.
  • The duration of infectiousness in animals that died or were euthanized was around 3.9 days, and 8.7 days in animals that survived. These durations are slightly different than the previous estimates of 4.4 and 6 days, respectively.
  • The case fatality rate was also found to be higher than previously estimated.

Implications

  • Using these updated parameters, the researchers revised the existing mathematical model of AHS infection. The revised model offered a more accurate representation, predicting more host deaths, a shorter duration for outbreaks, and a higher prevalence in vector species, compared to the earlier version.
  • This refined model could provide valuable insights for future studies on AHS and may inform better strategies for controlling or preventing outbreaks of this disease.

Cite This Article

APA
Fairbanks EL, Brennan ML, Mertens PPC, Tildesley MJ, Daly JM. (2022). Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search. Transbound Emerg Dis, 69(4), e671-e681. https://doi.org/10.1111/tbed.14420

Publication

Transboundary and emerging diseases
ISSN: 1865-1682
NlmUniqueID: 101319538
Country: Germany
Language: English
Volume: 69
Issue: 4
Pages: e671-e681

Researcher Affiliations

Fairbanks, Emma L
  • School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Brennan, Marnie L
  • School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Mertens, Peter P C
  • School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.
Tildesley, Michael J
  • The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, School of Life Sciences and Mathematics Institute, University of Warwick, Coventry, UK.
Daly, Janet M
  • School of Veterinary Medicine and Science, University of Nottingham, Nottingham, UK.

MeSH Terms

  • African Horse Sickness / epidemiology
  • African Horse Sickness Virus
  • Animals
  • Ceratopogonidae
  • Horse Diseases
  • Horses
  • Models, Theoretical
  • Viremia / veterinary

Grant Funding

  • BBS/E/I/00001144 / Biotechnology and Biological Sciences Research Council
  • BBS/E/I/00001446 / Biotechnology and Biological Sciences Research Council
  • 1944283 / BBSRC
  • 727293 PALE-Blu / EU H2020

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 81 references
  1. Aklilu N, Batten C, Gelaye E, Jenberie S, Ayelet G, Wilson A, Belay A, Asfaw Y, Oura C, Maan S, Bachanek‐Bankowska K, Mertens P P C. African horse sickness outbreaks caused by multiple virus types in Ethiopia. Transboundary and Emerging Diseases 61(2), 185–192.
    pubmed: 23083078
  2. Alberca B, Bachanek‐Bankowska K, Cabana M, Calvo‐Pinilla E, Viaplana E, Frost L, Gubbins S, Urniza A, Mertens P, Castillo‐Olivares J. Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge. Vaccine 32(29), 3670–3674.
    doi: 10.1016/j.vaccine.2014.04.036pmc: PMC4061461pubmed: 24837765google scholar: lookup
  3. Alexander R A, Du Toit P J. The immunization of horses and mules against horse sickness by means of the neurotropic virus of mice and guinea pigs. Onderstepoort Journal of Veterinary Research 2, 375–391.
  4. Allison K, Taylor N, Upton M, Wilsmore T. African horse sickness. Impact on the UK Horse Industry. .
  5. Anwar M, Qureshi M. Control and eradication of African horse sickness in Pakistan. Developmental Biology 199, 225–228.
  6. Bachanek‐Bankowska K, Maan S, Castillo‐Olivares J, Manning N M, Maan N S, Potgieter A C, Di Nardo A, Sutton G, Batten C, Mertens P P C. Real time RT‐PCR assays for detection and typing of African horse sickness virus. Plos One 9(4), e93758.
    pmc: PMC3983086pubmed: 24721971
  7. Backer J A, Nodelijk G. Transmission and control of African horse sickness in The Netherlands: A model analysis. Plos One 6(8), e23066.
    doi: 10.1371/journal.pone.0023066pmc: PMC3151287pubmed: 21850252google scholar: lookup
  8. Barba M, Fairbanks E L, Daly J. Equine viral encephalitis: Prevalence, impact, and management strategies. Veterinary Medicine 10, 99–110.
    doi: 10.2147/VMRR.S168227pmc: PMC6689664pubmed: 31497528google scholar: lookup
  9. Barnard B. Epidemiology of African horse sickness and the role of the zebra in South Africa. African Horse Sickness 13–19.
    doi: 10.1007/978-3-7091-6823-3pubmed: 9785491google scholar: lookup
  10. Baylis M, Hasnaoui H E, Bouayoune H, Touti J, Mellor P S. The spatial and seasonal distribution of African horse sickness and its potential Culicoides vectors in Morocco. Medical and Veterinary Entomology 11(3), 203–212.
    doi: 10.1111/j.1365-2915.1997.tb00397.xpubmed: 9330250google scholar: lookup
  11. Burrage T G, Trevejo R, Stone‐Marschat M, Laegreid W W. Neutralizing epitopes of African horsesickness virus serotype 4 are located on VP2. Virology 196(2), 799–803.
    doi: 10.1006/viro.1993.1537pubmed: 7690505google scholar: lookup
  12. Carpenter S, Mellor P S, Fall A G, Garros C, Venter G J. African horse sickness virus: History, transmission, and current status. Annual Review of Entomology 62, 343–358.
    doi: 10.1146/annurev-ento-031616-035010pubmed: 28141961google scholar: lookup
  13. Carpenter S, Wilson A, Barber J, Veronesi E, Mellor P, Venter G, Gubbins S. Temperature dependence of the extrinsic incubation period of orbiviruses in Culicoides biting midges. Plos One 6(11), e27987.
    doi: 10.1371/journal.pone.0027987pmc: PMC3220716pubmed: 22125649google scholar: lookup
  14. Castillo‐Olivares J. African horse sickness in Thailand: Challenges of controlling an outbreak by vaccination. Equine Veterinary Journal 53(1), 9–14.
    doi: 10.1111/evj.13353pmc: PMC7821295pubmed: 33007121google scholar: lookup
  15. Clemmons E A, Alfson K J, Dutton J W. Transboundary animal diseases, an overview of 17 diseases with potential for global spread and serious consequences. Animals 11(7), 2039.
    doi: 10.3390/ani11072039pmc: PMC8300273pubmed: 34359167google scholar: lookup
  16. Coetzee P, Van Vuuren M, Venter E H, Stokstad M. A review of experimental infections with bluetongue virus in the mammalian host. Virus Research 182, 21–34.
    doi: 10.1016/j.virusres.2013.12.044pmc: PMC7132480pubmed: 24462840google scholar: lookup
  17. Daly J M, Newton J R, Wood J L N, Park A W. What can mathematical models bring to the control of equine influenza?. Equine Veterinary Journal 45(6), 784–788.
    doi: 10.1111/evj.12104pmc: PMC3935405pubmed: 23679041google scholar: lookup
  18. Darpel K E, Monaghan P, Simpson J, Anthony S J, Veronesi E, Brooks H W, Elliott H, Brownlie J, Takamatsu H‐H, Mellor P S, Mertens P P. Involvement of the skin during bluetongue virus infection and replication in the ruminant host. Veterinary Research 43(1), 40.
    doi: 10.1186/1297-9716-43-40pmc: PMC3489507pubmed: 22546071google scholar: lookup
  19. Diouf N D, Etter E, Lo M M, Lo M, Akakpo A J. Outbreaks of African horse sickness in Senegal, and methods of control of the 2007 epidemic. Veterinary Record 172(6), 152.
    doi: 10.1136/vr.101083pubmed: 23223002google scholar: lookup
  20. Dubourget P, Preaud J, Detraz N, Lacoste F, Fabry A, Erasmus B, Lombard M. Development, production and quality control of an industrial inactivated vaccine against African horse sickness virus serotype 4. Bluetongue, African horse sickness and related orbiviruses 874–886.
  21. Du Plessis M, Cloete M, Aitchison H, Van Dijk A. Protein aggregation complicates the development of baculovirus‐expressed African horse sickness virus serotype 5 VP2 subunit vaccines. Onderstepoort Journal of Veterinary Research 65(4), 321–329.
    pubmed: 10192846
  22. Elbers A R W, Meiswinkel R. Culicoides (Diptera: Ceratopogonidae) and livestock in the Netherlands: Comparing host preference and attack rates on a Shetland pony, a dairy cow, and a sheep. Journal of Vector Ecology 40(2), 308–317.
    doi: 10.1111/jvec.12169pubmed: 26611966google scholar: lookup
  23. El Hasnaoui H, El Harrak M, Zientara S, Laviada M, Hamblin C. Serological and virological responses in mules and donkeys following inoculation with African horse sickness virus serotype 4. Archives of Virology Supplementum 14, 29–36.
    pubmed: 9785493
  24. Gerry A C, Mullens B A. Seasonal abundance and survivorship of Culicoides sonorensis (Diptera: Ceratopogonidae) at a southern California dairy, with reference to potential bluetongue virus transmission and persistence. Journal of Medical Entomology 37(5), 675–688.
    doi: 10.1603/0022-2585-37.5.675pubmed: 11004778google scholar: lookup
  25. Grassly N C, Fraser C. Mathematical models of infectious disease transmission. Nature Reviews Microbiology 6(6), 477–487.
    doi: 10.1038/nrmicro1845pmc: PMC7097581pubmed: 18533288google scholar: lookup
  26. Grewar J D, Kotze J L, Parker B J, Van Helden L S, Weyer C T. An entry risk assessment of African horse sickness virus into the controlled area of South Africa through the legal movement of equids. Plos One 16(5), e0252117.
    doi: 10.1371/journal.pone.0252117pmc: PMC8153453pubmed: 34038466google scholar: lookup
  27. Gubbins S, Turner J, Baylis M, Van Der Stede Y, Van Schaik G, Abrahantes J C, Wilson A J. Inferences about the transmission of Schmallenberg virus within and between farms. Preventive Veterinary Medicine 116(4), 380–390.
    doi: 10.1016/j.prevetmed.2014.04.011pmc: PMC4204990pubmed: 24857371google scholar: lookup
  28. Guimerà Busquets M, Pullinger G D, Darpel K E, Cooke L, Armstrong S, Simpson J, Palmarini M, Fragkoudis R, Mertens P P C. An early block in the replication of the atypical bluetongue virus serotype 26 in culicoides cells is determined by its capsid proteins. Viruses 13(5), 919.
    doi: 10.3390/v13050919pmc: PMC8156691pubmed: 34063508google scholar: lookup
  29. Guthrie A J, Maclachlan N J, Joone C, Lourens C W, Weyer C T, Quan M, Monyai M S, Gardner I A. Diagnostic accuracy of a duplex real‐time reverse transcription quantitative PCR assay for detection of African horse sickness virus. Journal of Virological Methods 189(1), 30–35.
    doi: 10.1016/j.jviromet.2012.12.014pubmed: 23291102google scholar: lookup
  30. Guthrie A J, Quan M, Lourens C W, Audonnet J‐C, Minke J M, Yao J, He L, Nordgren R, Gardner I A, Maclachlan N J. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co‐expressing genes encoding the outer capsid proteins of African horse sickness virus. Vaccine 27(33), 4434–4438.
    doi: 10.1016/j.vaccine.2009.05.044pubmed: 19490959google scholar: lookup
  31. Hassanain M M. Preliminary findings for an inactivated African horse sickness vaccine using binary ethyleneimine. Revue D Elevage Et De Medecine Veterinaire Des Pays Tropicaux 45(3–4), 231–234.
    pubmed: 1339986
  32. Hazrati A. Identification and typing of horse‐sickness virus strains isolated in the recent epizootic of the disease in Morocco, Tunisia and Algeria. Archives of Razi Institute 19(1), 131–143.
    doi: 10.22092/ari.1967.108632google scholar: lookup
  33. Hazrati A, Ozawa Y. Monovalent live‐virus horse‐sickness vaccine. Bulletin ‐ Office International Des Epizooties 64, 683–695.
    pubmed: 5895638
  34. House C, Mikiciuk P E, Beminger M L. Laboratory diagnosis of African horse sickness: Comparison of serological techniques and evaluation of storage methods of samples for virus isolation. Journal of Veterinary Diagnostic Investigation 2(1), 44–50.
    doi: 10.1177/104063879000200108pubmed: 2128615google scholar: lookup
  35. House J A, Lombard M, Dubourget P, House C, Mebus C A. Further studies on the efficacy of an inactivated African horse sickness serotype 4 vaccine. Vaccine 12(2), 142–144.
    doi: 10.1016/0264-410x(94)90052-3pubmed: 8147096google scholar: lookup
  36. House J A, Lombard M, House C, Dubourget P, Mebus C A. Efficacy of an inactivated vaccine for African horse sickness serotype 4. Bluetongue, African horse sickness and related orbiviruses 891–895.
    pubmed: 8147096
  37. Howell P. The 1960 epizootic of African horse sickness in the Middle East and SW Asia. Journal of the South African Veterinary Association 31(3), 329–334.
    doi: 10.10520/AJA00382809_817google scholar: lookup
  38. Jewell J E, Mecham J O. Identification of an amino acid on VP2 that affects neutralization of bluetongue virus serotype 10. Virus Research 33(2), 139–144.
    doi: 10.1016/0168-1702(94)90050-7pubmed: 7975878google scholar: lookup
  39. Lelli R, Molini U, Ronchi G F, Rossi E, Franchi P, Ulisse S, Armillotta G, Capista S, Khaiseb S, Ventura M D, Pini A. Inactivated and adjuvanted vaccine for the control of the African horse sickness virus serotype 9 infection: Evaluation of efficacy in horses and guinea‐pig model. Veterinaria Italiana 49(1), 89–98.
    pubmed: 23564590
  40. Liberati A, Altman D G, Tetzlaff J, Mulrow C, Gotzsche P C, Ioannidis J P A, Clarke M, Devereaux P J, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta‐analyses of studies that evaluate health care interventions: Explanation and elaboration. BMJ (Clinical Research Ed.) 339, b2700.
    doi: 10.1136/bmj.b2700pmc: PMC2714672pubmed: 19622552google scholar: lookup
  41. Lu G, Pan J, Ou J, Shao R, Hu X, Wang C, Li S. African horse sickness: Its emergence in Thailand and potential threat to other Asian countries. Transboundary and Emerging Diseases 67(5), 1751–1753.
    doi: 10.1111/tbed.13625pubmed: 32406171google scholar: lookup
  42. Lubroth J. African horsesickness and the epizootic in Spain 1987. Equine Practice (USA) 10(2), 26–33.
  43. Lulla V, Losada A, Lecollinet S, Kerviel A, Lilin T, Sailleau C, Beck C, Zientara S, Roy P. Protective efficacy of multivalent replication‐abortive vaccine strains in horses against African horse sickness virus challenge. Vaccine 35(33), 4262–4269.
    doi: 10.1016/j.vaccine.2017.06.023pmc: PMC5518735pubmed: 28625521google scholar: lookup
  44. Lulla V, Lulla A, Wernike K, Aebischer A, Beer M, Roy P. Assembly of replication‐incompetent African horse sickness virus particles: Rational design of vaccines for all serotypes. Journal of Virology 90(16), 7405–7414.
    doi: 10.1128/JVI.00548-16pmc: PMC4984648pubmed: 27279609google scholar: lookup
  45. Maclachlan N J. The pathogenesis and immunology of bluetongue virus infection of ruminants. Comparative Immunology, Microbiology and Infectious Diseases 17(3–4), 197–206.
    doi: 10.1016/0147-9571(94)90043-4pubmed: 8001345google scholar: lookup
  46. Maclachlan N J, Nunamaker R A, Katz J B, Sawyer M M, Akita G Y, Osburn B I, Tabachnick W J. Detection of bluetongue virus in the blood of inoculated calves: Comparison of virus isolation, PCR assay, and in vitro feeding of Culicoides variipennis. Archives of Virology 136(1–2), 1–8.
    doi: 10.1007/BF01538812pubmed: 8002778google scholar: lookup
  47. Martinez‐Torrecuadrada J L, Diaz‐Laviada M, Roy P, Sanchez C, Vela C, Sanchez‐Vizcaino J M, Casal J I. Full protection against African horsesickness (AHS) in horses induced by baculovirus‐derived AHS virus serotype 4 VP2, VP5 and VP7. Journal of General Virology 77(6), 1211–1221.
    doi: 10.1099/0022-1317-77-6-1211pubmed: 8683209google scholar: lookup
  48. Martínez‐Torrecuadrada J L, Díaz‐Laviada M, Roy P, Sánchez C, Vela C, Sánchez‐Vizcaíno J M, Casal J I. Serologic markers in early stages of African horse sickness virus infection. Journal of Clinical Microbiology 35(2), 531–535.
    pmc: PMC229621pubmed: 9003637
  49. Mayo C E, Weyer C T, Carpenter M J, Reed K J, Rodgers C P, Lovett K M, Guthrie A J, Mullens B A, Barker C M, Reisen W K, Maclachlan N J. Diagnostic applications of molecular and serological assays for bluetongue and African horse sickness. Revue Scientifique et Technique (International Office of Epizootics) 40(1), 91–104.
    doi: 10.20506/rst.40.1.3210pubmed: 34140738google scholar: lookup
  50. Meiswinkel R, Baylis M, Labuschagne K. Stabling and the protection of horses from Culicoides bolitinos (Diptera: Ceratopogonidae), a recently identified vector of African horse sickness. Bulletin of Entomological Research 90(6), 509–515.
    doi: 10.1017/S0007485300000626pubmed: 11107252google scholar: lookup
  51. Mellor P S, Hamblin C. African horse sickness. Veterinary Research 35(4), 445–466.
    doi: 10.1051/vetres:2004021pubmed: 15236676google scholar: lookup
  52. Minke J M, Audonnet J‐C, Guthrie A J, MacLachlan N J, Yao J. Vaccine against African horse sickness virus. (U.S. Patent No. 8,168,200).
  53. Mirchamsy H, Hazrati A. A review on aetiology and pathogeny of African horse sickness. Archives of Razi Institute 25(1), 23–46.
    doi: 10.22092/ARI.1973.108746google scholar: lookup
  54. Mirchamsy H, Taslimi H. Attempts to vaccinate foals with living tissue culture adapted horse sickness virus. Arch Inst Razi 17(1), 17–27.
    doi: 10.22092/ari.1965.108547google scholar: lookup
  55. Mirchamsy H, Taslimi H. Immunization against African horse‐sickness with tissue culture adapted neurotropic viruses. British veterinary Journal 120(10), 481–486.
    doi: 10.1016/S0007-1935(17)41556-9google scholar: lookup
  56. Mirchamsy H, Taslimi H. Inactivated African horse sickness virus cell culture vaccine. Immunology 14(1), 81–88.
    pmc: PMC1409248pubmed: 5635756
  57. Möhlmann T W R, Keeling M J, Wennergren U, Favia G, Santman‐Berends I, Takken W, Koenraadt C J M, Brand S P C. Biting midge dynamics and bluetongue transmission: A multiscale model linking catch data with climate and disease outbreaks. Scientific Reports 11(1), 1–16.
    doi: 10.1038/s41598-021-81096-9pmc: PMC7820592pubmed: 33479304google scholar: lookup
  58. Mullens B, Gerry A, Lysyk T, Schmidtmann E. Environmental effects on vector competence and virogenesis of bluetongue virus in Culicoides: Interpreting laboratory data in a field context. Veterinaria Italiana 40(3), 160–166.
    pubmed: 20419655
  59. Ozawa Y, Bahrami S. African horse‐sickness killed‐virus tissue culture vaccine. Canadian Journal of Comparative Medicine and Veterinary Science 30(11), 311–314.
    pmc: PMC1494603pubmed: 4226381
  60. Ozawa Y, Hazrati A, Bahrami S. African horse‐sickness live and killed virus tissue culture vaccine. Archives of Razi Institute 22, 103–111.
  61. Ozawa Y, Hazrati A, Erol N. African horse‐sickness live‐virus tissue culture vaccine. Archives of Razi Institute 18, 61–84.
    pubmed: 14266922
  62. Portas M, Boinas F S, Sousa J O E, Rawlings P. African horse sickness in Portugal: A successful eradication programme. Epidemiology and Infection 123(2), 337–346.
    doi: 10.1017/S0950268899002897pmc: PMC2810767pubmed: 10579455google scholar: lookup
  63. Pullinger G D, Guimerà Busquets M, Nomikou K, Boyce M, Attoui H, Mertens P P. Identification of the genome segments of bluetongue virus serotype 26 (isolate kuw2010/02) that restrict replication in a Culicoides sonorensis cell line (kc cells). Plos One 11(2), e0149709.
    doi: 10.1371/journal.pone.0149709pmc: PMC4758653pubmed: 26890863google scholar: lookup
  64. Quan M, Lourens C W, Maclachlan N J, Gardner I A, Guthrie A J. Development and optimisation of a duplex real‐time reverse transcription quantitative PCR assay targeting the VP7 and NS2 genes of African horse sickness virus. Journal of Virological Methods 167(1), 45–52.
    doi: 10.1016/j.jviromet.2010.03.009pubmed: 20304015google scholar: lookup
  65. R Core Team and contributors worldwide. Stats: The R Stats Package version 4.2.0 [Computer software manual]. .
  66. Robin M, Archer D, Mcgowan C, Garros C, Gardès L, Baylis M. Repellent effect of topical deltamethrin on blood feeding by Culicoides on horses. Veterinary Record 176(22), 574.
    doi: 10.1136/vr.102800pubmed: 25948630google scholar: lookup
  67. Robin M, Page P, Archer D, Baylis M. African horse sickness: The potential for an outbreak in disease‐free regions and current disease control and elimination techniques. Equine Veterinary Journal 48(5), 659–669.
    doi: 10.1111/evj.12600pubmed: 27292229google scholar: lookup
  68. Rodriguez M, Hooghuis H, Castaño M a. African horse sickness in Spain. Veterinary Microbiology 33(1–4), 129–142.
    doi: 10.1016/0378-1135(92)90041-Qpubmed: 1481352google scholar: lookup
  69. Roy P, Bishop D H L, Howard S, Aitchison H, Erasmus B. Recombinant baculovirus‐synthesized African horse sickness virus (AHSV) outer‐capsid protein VP2 provides protection against virulent AHSV challenge. Journal of General Virology 77(9), 2053–2057.
    doi: 10.1099/0022-1317-77-9-2053pubmed: 8811002google scholar: lookup
  70. Sailleau C, Moulay S, Cruciere C, Laegreid W W, Zientara S. Detection of African horse sickness virus in the blood of experimentally infected horses: Comparison of virus isolation and a PCR assay. Research in Veterinary Science 62(3), 229–232.
    doi: 10.1016/S0034-5288(97)90195-8pubmed: 9300539google scholar: lookup
  71. Sánchez‐Matamoros A, Nieto‐Pelegrín E, Beck C, Rivera‐Arroyo B, Lecollinet S, Sailleau C, Zientara S, Sánchez‐Vizcaíno J M. Development of a luminex‐based DIVA assay for serological detection of african horse sickness virus in horses. Transboundary and Emerging Diseases 63(4), 353–359.
    doi: 10.1111/tbed.12503pubmed: 27090377google scholar: lookup
  72. Scanlen M, Paweska J T, Verschoor J A, Van Dijk A A. The protective efficacy of a recombinant VP2‐based African horse sickness subunit vaccine candidate is determined by adjuvant. Vaccine 20(7‐8), 1079–1088.
    doi: 10.1016/s0264-410x(01)00445-5pubmed: 11803068google scholar: lookup
  73. Stone‐Marschat M A, Moss S R, Burrage T G, Barber M L, Roy P, Laegreid W W. Immunization with VP2 is sufficient for protection against lethal challenge with African horse sickness virus Type 4. Virology 220(1), 219–222.
    doi: 10.1006/viro.1996.0304pubmed: 8659117google scholar: lookup
  74. Van Rijn P A, Maris‐Veldhuis M A, Grobler M, Wright I M, Erasmus B J, Maartens L H, Potgieter C A. Safety and efficacy of inactivated African horse sickness (AHS) vaccine formulated with different adjuvants. Vaccine 38(45), 7108–7117.
    doi: 10.1016/j.vaccine.2020.08.072pubmed: 32921506google scholar: lookup
  75. Van Rijn P A, Maris‐Veldhuis M A, Potgieter C A, Van Gennip R G P. African horse sickness virus (AHSV) with a deletion of 77 amino acids in NS3/NS3a protein is not virulent and a safe promising AHS Disabled Infectious Single Animal (DISA) vaccine platform. Vaccine 36(15), 1925–1933.
    doi: 10.1016/j.vaccine.2018.03.003pubmed: 29525278google scholar: lookup
  76. Theiler A. African horse sickness. Science Bulletin 19, 131–143.
    doi: 10.22092/ari.1967.108632google scholar: lookup
  77. Umeshappa C S, Singh K P, Channappanavar R, Sharma K, Nanjundappa R H, Saxena M, Singh R, Sharma A K. A comparison of intradermal and intravenous inoculation of bluetongue virus serotype 23 in sheep for clinico‐pathology, and viral and immune responses. Veterinary Immunology and Immunopathology 141(3–4), 230–238.
    doi: 10.1016/j.vetimm.2011.03.005pubmed: 21511346google scholar: lookup
  78. Von Teichman B F, Dungu B, Smit T K. In vivo cross‐protection to African horse sickness Serotypes 5 and 9 after vaccination with Serotypes 8 and 6. Vaccine 28(39), 6505–6517.
    doi: 10.1016/j.vaccine.2010.06.105pubmed: 20638456google scholar: lookup
  79. Whitworth S. Memorandum on horse‐sickness immunization. In Papers veterinary section, no. 30. Union of South Africa, Dept. of Agriculture; Pretoria: University of Pretoria, Dept. of Library Services (Digital publisher) .
  80. Wittmann E J, Mellor P S, Baylis M. Effect of temperature on the transmission of orbiviruses by the biting midge, Culicoides sonorensis. Medical and Veterinary Entomology 16(2), 147–156.
    doi: 10.1046/j.1365-2915.2002.00357.xpubmed: 12109708google scholar: lookup
  81. World Organisation for Animal Health (OIE). Infection with African horse sickness virus ‐ article 12.1.2. .
Subscribe to our newsletter
Join 99,357 horse owners like you who receive our email updates on horse health and nutrition.